Alvino Mark 4

What Happened
Mark Alvino, a director of Abeona Therapeutics, disposed of 2,000 shares on February 2, 2026 in open-market/private sales. The shares were sold for a weighted average price of about $5.09–$5.12 per share, producing roughly $10,181 in proceeds. This was a sale (code S) and, per the filing, was done to cover tax obligations tied to the vesting of restricted stock awards.

Key Details

• Transaction date: 2026-02-02 (filing date: 2026-02-02).
• Price: weighted average reported ~$5.09; individual sale prices ranged $5.09–$5.12 (footnote F2).
• Shares sold: 2,000; estimated proceeds ~$10,181.
• Reason noted: sale to cover tax withholding on vested restricted stock (footnote F1).
• Shares owned after the transaction: not specified in the provided Form 4 summary.
• Filing timeliness: transaction and report share the same date (no late filing indicated).
• Additional note: the filer can provide exact breakdown of shares sold at each price within the $5.09–$5.12 range upon request (F2).

Context
Sales executed to meet tax withholding from restricted stock vesting are common administrative transactions and do not, by themselves, indicate a change in an insider’s view of the company. This was a director-level sale (not a 10% owner disclosure) and not an exercise/gift/10b5-1 purchase.